| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Dermatology, Virchow Hospital, Humboldt-Universität zu Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany [R. P., M. B. S., B. H., B. M. H.]; Research Laboratories, Schering AG, Experimental Dermatology, D-13342 Berlin, Germany [M. B. S., A. M.]; and Institute of Molecular Biology, Jagiellonian University, Krakow, Poland [P. P.]
Using a murine model that mimics chemotherapy-induced alopecia (CIA) in humans particularly well, we show here that in contrast to previously reported CIA-protective effects in neonatal rats, topical calcitriol does not prevent CIA in adolescent mice but enhances the regrowth of normally pigmented hair shafts. When, prior to injecting 1 x 120 mg/kg cyclophosphamide i.p., 0.2 µg calcitriol or vehicle alone were administered topically to the back skin of C57BL/6 mice with all hair follicles in anagen, no significant macroscopic differences in the onset and severity of CIA were seen. However, hair shaft regrowth after CIA, which is often retarded and patchy, thus displaying severe and sometimes persistent pigmentation disorders, was significantly accelerated, enhanced, and qualitatively improved in test compared with control mice. Histomorphometric analysis suggests that this is related to the fact that calcitriol-pretreated follicles favor the "dystrophic catagen pathway" of response to chemical injury, i.e., a follicular repair strategy allowing for the unusually fast reconstruction of a new, undamaged anagen hair bulb. Thus, it may be unrealistic to expect that topical calcitriol can prevent human CIA, but topical calcitriols may well enhance the regrowth of a normal hair coat.
1 This study was supported in part by Deutsche Krebshilfe Grant W 1/9 Pa 1 (R. P.), a fellowship from Schering AG (M. B. S.), and a scholarship from the Foundation for Polish Science (P. P.).
2 To whom requests for reprints should be addressed, Phone: 49-30-45065043; Fax: 49-30-45065900; E-mail: ralfpaus@ukrv.de.
Received 1/29/96. Accepted 8/ 1/96.
This article has been cited by other articles:
![]() |
E. Bodo, D. J. Tobin, Y. Kamenisch, T. Biro, M. Berneburg, W. Funk, and R. Paus Dissecting the Impact of Chemotherapy on the Human Hair Follicle: A Pragmatic in Vitro Assay for Studying the Pathogenesis and Potential Management of Hair Follicle Dystrophy Am. J. Pathol., October 1, 2007; 171(4): 1153 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Ohnemus, M. Uenalan, F. Conrad, B. Handjiski, L. Mecklenburg, M. Nakamura, J. Inzunza, J.-A. Gustafsson, and R. Paus Hair Cycle Control by Estrogens: Catagen Induction via Estrogen Receptor (ER)-{alpha} Is Checked by ER{beta} Signaling Endocrinology, March 1, 2005; 146(3): 1214 - 1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Sharov, F. Siebenhaar, T. Y. Sharova, N. V. Botchkareva, B. A. Gilchrest, and V. A. Botchkarev Fas Signaling Is Involved in the Control of Hair Follicle Response to Chemotherapy Cancer Res., September 1, 2004; 64(17): 6266 - 6270. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Siderov Calcitriol and Alopecia--Is it the Hair Apparent? J. Clin. Oncol., May 15, 2003; 21(10): 2044 - 2045. [Full Text] [PDF] |
||||
![]() |
N. Sato, P. L. Leopold, and R. G. Crystal Effect of Adenovirus-Mediated Expression of Sonic Hedgehog Gene on Hair Regrowth in Mice With Chemotherapy-Induced Alopecia J Natl Cancer Inst, December 19, 2001; 93(24): 1858 - 1864. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Botchkarev, E. A. Komarova, F. Siebenhaar, N. V. Botchkareva, A. A. Sharov, P. G. Komarov, M. Maurer, A. V. Gudkov, and B. A. Gilchrest p53 Involvement in the Control of Murine Hair Follicle Regression Am. J. Pathol., June 1, 2001; 158(6): 1913 - 1919. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Slominski and J. Wortsman Neuroendocrinology of the Skin Endocr. Rev., October 1, 2000; 21(5): 457 - 487. [Abstract] [Full Text] |
||||
![]() |
V. A. Botchkarev, E. A. Komarova, F. Siebenhaar, N. V. Botchkareva, P. G. Komarov, M. Maurer, B. A. Gilchrest, and A. V. Gudkov p53 Is Essential for Chemotherapy-induced Hair Loss Cancer Res., September 1, 2000; 60(18): 5002 - 5006. [Abstract] [Full Text] |
||||
![]() |
G. LINDNER, A. MENRAD, E. GHERARDI, G. MERLINO, P. WELKER, B. HANDJISKI, B. ROLOFF, and R. PAUS Involvement of hepatocyte growth factor/scatter factor and Met receptor signaling in hair follicle morphogenesis and cycling FASEB J, February 1, 2000; 14(2): 319 - 332. [Abstract] [Full Text] |
||||
![]() |
V. A. BOTCHKAREV, N. V. BOTCHKAREVA, P. WELKER, M. METZ, G. R. LEWIN, A. SUBRAMANIAM, S. BULFONE-PAUS, E. HAGEN, A. BRAUN, M. LOMMATZSCH, et al. A new role for neurotrophins: involvement of brain-derived neurotrophic factor and neurotrophin-4 in hair cycle control FASEB J, February 1, 1999; 13(2): 395 - 410. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |